MIDDLE EAST AND TURKEY HEMOPHILIA TREATMENT MARKET ANALYSIS

Middle East and Turkey Hemophilia Treatment Market, By Product Type (Recombinant Coagulation Factor, Plasma Derived Coagulation Factor, Antifibrinolytic Agents, and Desmopressin), By Disease Indication (Hemophilia A, Hemophilia B, and Hemophilia C), and By Country (Turkey, Egypt, Israel, Saudi Arabia, UAE, and Rest of Middle East)-

Published In : Apr 2023
Code : CMI3250
Pages :230
Formats :
Excel and PDF
Industry : Pharmaceutical

Leading Companies

By Product Type: Recombinant Coagulation Factor, Plasma Derived Coagulation Factor, Antifibrinolytic Agents, Desmopressin
By Disease Indication: Hemophilia A, Hemophilia B, Hemophilia C

Takeda Pharmaceutical Company Limited., Sanofi S.A., Octapharma AG, Swedish Orphan Biovitrum AB, Baxter International Inc., Biogen Inc., Bayer AG, CSL Behring, Ferring B.V., Pfizer, Inc., Kedrion, Novo Nordisk A/S, Grifols S.A., Sangamo Therapeutics, Inc., and Spark Therapeutics, Inc.